首页 > 最新文献

Pneumologie最新文献

英文 中文
Hurdles on the way to the diagnosis of asthma and successful therapy. 诊断哮喘和成功治疗路上的障碍。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-10 DOI: 10.1055/a-2319-4464
Thomas Hausen

There are many potential hurdles, obviously at the forefront of patient care which may impede the correct and early diagnosis of asthma, as well as successful, appropriate treatment. Although the illness is often accompanied by many typical signs which may enable a rapid diagnosis, these are often overlooked or misinterpreted. Symptoms may not be recognised or confused with others, such as respiratory infections, and inappropriate diagnostic tests used. Inappropriate therapy (absent or insufficient dosage of a topical anti-inflammatory and/or exclusive usage of a short-acting beta-agonist) and failure to adapt therapy may further impede the patient's chance to live without symptoms.

显然,在病人护理的最前沿,有许多潜在的障碍可能会妨碍对哮喘的正确和早期诊断,以及成功和适当的治疗。虽然哮喘病常伴有许多典型的体征,可以帮助快速诊断,但这些体征常常被忽视或误解。症状可能未被识别或与其他症状(如呼吸道感染)混淆,也可能使用了不恰当的诊断检测。不恰当的治疗(未使用或未足量使用局部消炎药和/或仅使用短效β-受体激动剂)和未调整治疗方法可能会进一步阻碍患者在没有症状的情况下生活。
{"title":"Hurdles on the way to the diagnosis of asthma and successful therapy.","authors":"Thomas Hausen","doi":"10.1055/a-2319-4464","DOIUrl":"https://doi.org/10.1055/a-2319-4464","url":null,"abstract":"<p><p>There are many potential hurdles, obviously at the forefront of patient care which may impede the correct and early diagnosis of asthma, as well as successful, appropriate treatment. Although the illness is often accompanied by many typical signs which may enable a rapid diagnosis, these are often overlooked or misinterpreted. Symptoms may not be recognised or confused with others, such as respiratory infections, and inappropriate diagnostic tests used. Inappropriate therapy (absent or insufficient dosage of a topical anti-inflammatory and/or exclusive usage of a short-acting beta-agonist) and failure to adapt therapy may further impede the patient's chance to live without symptoms.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141301418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[EBUS-guided cryobiopsy in the diagnosis of mediastinal lesions - step by step]. [EBUS引导下的冷冻生物切片检查在纵隔病变诊断中的应用--循序渐进]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-01 Epub Date: 2024-06-12 DOI: 10.1055/a-2295-5921
Erik Büscher, Ruediger Karpf-Wissel, Faustina Funke, Kaid Darwiche

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the gold standard in the diagnosis of mediastinal and hilar lesions. For certain purposes, such as the diagnosis and subtyping of lymphoproliferative disorders or molecular pathology, a larger amount of intact sample material is required. EBUS cryobiopsy is a new and efficient tool for this purpose. As it is a new approach, there is still no standardised workflow. In this review, we present the procedure step by step as it is performed at the Ruhrlandklinik in Essen.

支气管内超声引导下经支气管针吸术(EBUS-TBNA)是诊断纵隔和肺门病变的金标准。在某些情况下,如淋巴增生性疾病或分子病理学的诊断和亚型鉴定,需要更大量的完整样本材料。为此,EBUS 冷冻活检是一种新的高效工具。由于这是一种新方法,目前还没有标准化的工作流程。在这篇综述中,我们将逐步介绍埃森鲁尔医院的操作流程。
{"title":"[EBUS-guided cryobiopsy in the diagnosis of mediastinal lesions - step by step].","authors":"Erik Büscher, Ruediger Karpf-Wissel, Faustina Funke, Kaid Darwiche","doi":"10.1055/a-2295-5921","DOIUrl":"10.1055/a-2295-5921","url":null,"abstract":"<p><p>Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the gold standard in the diagnosis of mediastinal and hilar lesions. For certain purposes, such as the diagnosis and subtyping of lymphoproliferative disorders or molecular pathology, a larger amount of intact sample material is required. EBUS cryobiopsy is a new and efficient tool for this purpose. As it is a new approach, there is still no standardised workflow. In this review, we present the procedure step by step as it is performed at the Ruhrlandklinik in Essen.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"78 6","pages":"420-426"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141311493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Home mechancial ventilation: quality of life and the final stage of life]. [家庭机械通气:生活质量和生命的最后阶段]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-01 Epub Date: 2024-01-10 DOI: 10.1055/a-2202-5558
Sarah Bettina Stanzel, Bernd Schönhofer

The evaluation of health-related quality of life (HRQL) has gained importance in recent years. Disease-specific questionnaires are available for respiratory insufficiency, which enable the assessment of HRQL. The Severe Respiratory Insufficiency (SRI) questionnaire, which was specially developed for patients with respiratory insufficiency, is ideal for quantifying the quality of life in patients receiving home mechanical ventilation (HMV). Studies using the SRI questionnaire demonstrated that the physical functioning of patients with chronic lung diseases of various etiologies is significantly impaired, but frequently without significant impairment of psychological well-being. Therefore, severity of the disease and HRQL do not necessarily correlate with each other.Both invasive and non-invasive mechanical ventilation can improve quality of life. Co-morbidity, and above all advanced age, have the highest negative predictive value with regard to in-hospital mortality and weaning failure. The number of patients older than 80 years who remain dependent on invasive HMV after prolonged weaning in Germany is increasing significantly. High dependence on invasive HMV is often associated with a loss of quality of life and autonomy. Thus, ethical issues of the continued treatment of ventilated patients at the end of life are discussed increasingly.After weaning failure, the indication for invasive HMV should be critically examined and should focus on potentially severely reduced quality of life and poor prognosis, as well as the patient's wishes. If previously agreed treatment goals can no longer be achieved during the course of invasive HMV, changing the therapy goals should be discussed within the clinical team, with the patient, their relatives and, if necessary, with legal representatives.In order to avoid overtreatment and unnecessary patient suffering during invasive HMV, advanced care planning should be started as early as possible and if necessary accompanied by palliative medical measures.

近年来,对健康相关生活质量(HRQL)的评估越来越重要。针对呼吸功能不全的疾病特异性问卷可用于评估 HRQL。严重呼吸功能不全(SRI)问卷是专为呼吸功能不全患者开发的,是量化接受家庭机械通气(HMV)患者生活质量的理想工具。使用 SRI 问卷进行的研究表明,各种病因导致的慢性肺部疾病患者的身体机能明显受损,但心理健康往往没有明显受损。因此,疾病的严重程度与生活质量和舒适度并不一定相互关联。有创和无创机械通气都能提高生活质量。并发症,尤其是高龄,对院内死亡率和断奶失败的负预测值最高。在德国,80 岁以上的患者在长时间断奶后仍依赖有创 HMV 的人数正在显著增加。对有创高压氧治疗的高度依赖往往与生活质量和自主性的丧失有关。因此,人们越来越多地讨论在生命末期继续对通气患者进行治疗的伦理问题。断气失败后,应严格审查有创高压氧治疗的适应症,重点关注可能严重降低的生活质量和不良预后,以及患者的意愿。如果在有创高压氧治疗过程中无法再实现之前商定的治疗目标,则应在临床团队内部与患者及其亲属讨论改变治疗目标,必要时还应与法律代表讨论。为了避免过度治疗和患者在侵入性 HMV 期间遭受不必要的痛苦,应尽早启动晚期护理计划,并在必要时辅以姑息性医疗措施。
{"title":"[Home mechancial ventilation: quality of life and the final stage of life].","authors":"Sarah Bettina Stanzel, Bernd Schönhofer","doi":"10.1055/a-2202-5558","DOIUrl":"10.1055/a-2202-5558","url":null,"abstract":"<p><p>The evaluation of health-related quality of life (HRQL) has gained importance in recent years. Disease-specific questionnaires are available for respiratory insufficiency, which enable the assessment of HRQL. The Severe Respiratory Insufficiency (SRI) questionnaire, which was specially developed for patients with respiratory insufficiency, is ideal for quantifying the quality of life in patients receiving home mechanical ventilation (HMV). Studies using the SRI questionnaire demonstrated that the physical functioning of patients with chronic lung diseases of various etiologies is significantly impaired, but frequently without significant impairment of psychological well-being. Therefore, severity of the disease and HRQL do not necessarily correlate with each other.Both invasive and non-invasive mechanical ventilation can improve quality of life. Co-morbidity, and above all advanced age, have the highest negative predictive value with regard to in-hospital mortality and weaning failure. The number of patients older than 80 years who remain dependent on invasive HMV after prolonged weaning in Germany is increasing significantly. High dependence on invasive HMV is often associated with a loss of quality of life and autonomy. Thus, ethical issues of the continued treatment of ventilated patients at the end of life are discussed increasingly.After weaning failure, the indication for invasive HMV should be critically examined and should focus on potentially severely reduced quality of life and poor prognosis, as well as the patient's wishes. If previously agreed treatment goals can no longer be achieved during the course of invasive HMV, changing the therapy goals should be discussed within the clinical team, with the patient, their relatives and, if necessary, with legal representatives.In order to avoid overtreatment and unnecessary patient suffering during invasive HMV, advanced care planning should be started as early as possible and if necessary accompanied by palliative medical measures.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"409-416"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139417874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]. [CF 肺病--德国 S3 指南:铜绿假单胞菌]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-01 Epub Date: 2024-02-29 DOI: 10.1055/a-2278-6685
Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Stephan Illing, Jochen G Mainz, Ernst Rietschel, Sebastian Schmidt, Bernhard Schulte-Hubbert, Helmut Sitter, Marc Oliver Wielpütz, Jutta Hammermann, Ingo Baumann, Frank Brunsmann, Doris Dieninghoff, Ernst Eber, Helmut Ellemunter, Patience Eschenhagen, Caroline Evers, Saskia Gruber, Assen Koitschev, Julia Ley-Zaporozhan, Uta Düesberg, Hans-Joachim Mentzel, Thomas Nüßlein, Felix C Ringshausen, Ludwig Sedlacek, Christina Smaczny, Olaf Sommerburg, Sivagurunathan Sutharsan, Ralf-Peter Vonberg, Ann-Katrin Weber, Jovita Zerlik
{"title":"[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa].","authors":"Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Stephan Illing, Jochen G Mainz, Ernst Rietschel, Sebastian Schmidt, Bernhard Schulte-Hubbert, Helmut Sitter, Marc Oliver Wielpütz, Jutta Hammermann, Ingo Baumann, Frank Brunsmann, Doris Dieninghoff, Ernst Eber, Helmut Ellemunter, Patience Eschenhagen, Caroline Evers, Saskia Gruber, Assen Koitschev, Julia Ley-Zaporozhan, Uta Düesberg, Hans-Joachim Mentzel, Thomas Nüßlein, Felix C Ringshausen, Ludwig Sedlacek, Christina Smaczny, Olaf Sommerburg, Sivagurunathan Sutharsan, Ralf-Peter Vonberg, Ann-Katrin Weber, Jovita Zerlik","doi":"10.1055/a-2278-6685","DOIUrl":"10.1055/a-2278-6685","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"e2"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139997229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reexpansion pulmonary edema after treatment of primary spontaneous pneumothorax. 原发性自发性气胸治疗后的再膨胀性肺水肿。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-01 Epub Date: 2023-12-14 DOI: 10.1055/a-2216-0404
Fabian Gleibs, Felix Döllinger, Martin Witzenrath, Ralf-Harto Huebner, Jacopo Saccomanno

A 24-year-old male patient, without further symptoms or comorbidities presented to the emergency room with acute dyspnea after heavy lifting two days before. On auscultation an attenuated vesicular breath was noticed on the right lung. In the initial chest radiograph a right-sided primary spontaneous pneumothorax with minor mediastinal shift was diagnosed. After insertion of a 12-French chest tube the patient's clinical condition deteriorated. The following chest radiograph and computed tomography of the thorax showed a reexpansion pulmonary edema in the right lung. The patient was admitted to the ICU and supportive treatment was initiated. Pulmonary reexpansion edema after drainage of a pneumothorax is a very rare complication with mortality rates reaching up to 20%. The exact pathophysiology remains unknown. Typical Symptoms include dyspnea, hypotension, and tachycardia. To minimize the risk of a pulmonary reexpansion edema, not more than 1200-1800 ml of air should be drained at once and the drainage should be stopped when the patient starts coughing.

急诊室接诊了一名 24 岁的男性患者,无其他症状或合并症,两天前曾因搬运重物而出现急性呼吸困难。听诊时发现右肺有减弱的水泡样呼吸。初步胸片诊断为右侧原发性自发性气胸,纵隔轻微移位。插入 12 法分胸管后,患者的临床状况恶化。随后的胸片和胸部计算机断层扫描显示右肺出现再膨胀性肺水肿。患者被送入重症监护室,并开始接受支持性治疗。气胸引流后出现肺再膨胀水肿是一种非常罕见的并发症,死亡率高达 20%。确切的病理生理学至今仍不清楚。典型症状包括呼吸困难、低血压和心动过速。为了最大限度地降低肺再膨胀水肿的风险,一次排气量不应超过 1200-1800 毫升,当患者开始咳嗽时应停止排气。
{"title":"Reexpansion pulmonary edema after treatment of primary spontaneous pneumothorax.","authors":"Fabian Gleibs, Felix Döllinger, Martin Witzenrath, Ralf-Harto Huebner, Jacopo Saccomanno","doi":"10.1055/a-2216-0404","DOIUrl":"10.1055/a-2216-0404","url":null,"abstract":"<p><p>A 24-year-old male patient, without further symptoms or comorbidities presented to the emergency room with acute dyspnea after heavy lifting two days before. On auscultation an attenuated vesicular breath was noticed on the right lung. In the initial chest radiograph a right-sided primary spontaneous pneumothorax with minor mediastinal shift was diagnosed. After insertion of a 12-French chest tube the patient's clinical condition deteriorated. The following chest radiograph and computed tomography of the thorax showed a reexpansion pulmonary edema in the right lung. The patient was admitted to the ICU and supportive treatment was initiated. Pulmonary reexpansion edema after drainage of a pneumothorax is a very rare complication with mortality rates reaching up to 20%. The exact pathophysiology remains unknown. Typical Symptoms include dyspnea, hypotension, and tachycardia. To minimize the risk of a pulmonary reexpansion edema, not more than 1200-1800 ml of air should be drained at once and the drainage should be stopped when the patient starts coughing.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"417-419"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]. [CF肺病--德国S3指南:铜绿假单胞菌]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-06-01 Epub Date: 2024-02-13 DOI: 10.1055/a-2182-1907
Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Stephan Illing, Jochen G Mainz, Ernst Rietschel, Sebastian Schmidt, Bernhard Schulte-Hubbert, Helmut Sitter, Marc Oliver Wielpütz, Jutta Hammermann, Ingo Baumann, Frank Brunsmann, Doris Dieninghoff, Ernst Eber, Helmut Ellemunter, Patience Eschenhagen, Caroline Evers, Saskia Gruber, Assen Koitschev, Julia Ley-Zaporozhan, Uta Düesberg, Hans-Joachim Mentzel, Thomas Nüßlein, Felix C Ringshausen, Ludwig Sedlacek, Christina Smaczny, Olaf Sommerburg, Sivagurunathan Sutharsan, Ralf-Peter Vonberg, Ann-Katrin Weber, Jovita Zerlik

Cystic Fibrosis (CF) is the most common autosomal recessive genetic multisystemic disease. In Germany, it affects at least 8000 people. The disease is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to dysfunction of CFTR, a transmembrane chloride channel. This defect causes insufficient hydration of the airway epithelial lining fluid which leads to reduction of the mucociliary clearance.Even if highly effective, CFTR modulator therapy has been available for some years and people with CF are getting much older than before, recurrent and chronic infections of the airways as well as pulmonary exacerbations still occur. In adult CF life, Pseudomonas aeruginosa (PA) is the most relevant pathogen in colonisation and chronic infection of the lung, leading to further loss of lung function. There are many possibilities to treat PA-infection.This is a S3-clinical guideline which implements a definition for chronic PA-infection and demonstrates evidence-based diagnostic methods and medical treatment in order to give guidance for individual treatment options.

囊性纤维化(CF)是最常见的常染色体隐性遗传多系统疾病。在德国,至少有 8000 人患有此病。该病是由囊性纤维化跨膜传导调节器(CFTR)基因突变导致跨膜氯离子通道 CFTR 功能障碍引起的。即使高效的 CFTR 调节器疗法已经问世多年,CF 患者的年龄也比以前大得多,但气道的反复和慢性感染以及肺部恶化仍时有发生。在成年 CF 患者中,铜绿假单胞菌(PA)是肺部定植和慢性感染的最主要病原体,会导致肺功能进一步丧失。治疗 PA 感染的方法有很多种。这是一份 S3 级临床指南,其中对慢性 PA 感染进行了定义,并展示了循证诊断方法和药物治疗,以便为个体治疗方案提供指导。
{"title":"[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa].","authors":"Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Stephan Illing, Jochen G Mainz, Ernst Rietschel, Sebastian Schmidt, Bernhard Schulte-Hubbert, Helmut Sitter, Marc Oliver Wielpütz, Jutta Hammermann, Ingo Baumann, Frank Brunsmann, Doris Dieninghoff, Ernst Eber, Helmut Ellemunter, Patience Eschenhagen, Caroline Evers, Saskia Gruber, Assen Koitschev, Julia Ley-Zaporozhan, Uta Düesberg, Hans-Joachim Mentzel, Thomas Nüßlein, Felix C Ringshausen, Ludwig Sedlacek, Christina Smaczny, Olaf Sommerburg, Sivagurunathan Sutharsan, Ralf-Peter Vonberg, Ann-Katrin Weber, Jovita Zerlik","doi":"10.1055/a-2182-1907","DOIUrl":"10.1055/a-2182-1907","url":null,"abstract":"<p><p>Cystic Fibrosis (CF) is the most common autosomal recessive genetic multisystemic disease. In Germany, it affects at least 8000 people. The disease is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to dysfunction of CFTR, a transmembrane chloride channel. This defect causes insufficient hydration of the airway epithelial lining fluid which leads to reduction of the mucociliary clearance.Even if highly effective, CFTR modulator therapy has been available for some years and people with CF are getting much older than before, recurrent and chronic infections of the airways as well as pulmonary exacerbations still occur. In adult CF life, <i>Pseudomonas aeruginosa</i> (PA) is the most relevant pathogen in colonisation and chronic infection of the lung, leading to further loss of lung function. There are many possibilities to treat PA-infection.This is a S3-clinical guideline which implements a definition for chronic PA-infection and demonstrates evidence-based diagnostic methods and medical treatment in order to give guidance for individual treatment options.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"367-399"},"PeriodicalIF":1.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139730370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Everything under control?] [一切尽在掌握? ]
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-05-23 DOI: 10.1055/a-2313-4137
Johanna Eggeling, Barbara Kalsdorf, Dagmar Schaub, Stefanie Schierholz, Peter Hammerl, Dennis Nowak, Christoph Lange

A 43-year-old quarry worker, after being exposed to fine quartz dust for 16 years in a German quarry, is on the waiting list for a lung transplant. The inhalation of the fine dust irreversibly damaged his lungs and facilitated the occurrence of fulminant mycobacterial and fungal infections, which have already led to a unilateral pneumonectomy and increasing respiratory failure. Despite regular monitoring by the occupational health and safety board, this dramatic development of silicosis could not be prevented.

一名 43 岁的采石场工人在德国一家采石场工作 16 年之久,一直暴露于细微的石英粉尘中,目前正在等待肺移植手术。吸入的微尘对他的肺部造成了不可逆转的损害,并引发了严重的霉菌和真菌感染,已经导致单侧肺切除术和呼吸衰竭。尽管职业健康和安全委员会定期进行监测,但仍无法防止矽肺病的急剧发展。
{"title":"[Everything under control?]","authors":"Johanna Eggeling, Barbara Kalsdorf, Dagmar Schaub, Stefanie Schierholz, Peter Hammerl, Dennis Nowak, Christoph Lange","doi":"10.1055/a-2313-4137","DOIUrl":"10.1055/a-2313-4137","url":null,"abstract":"<p><p>A 43-year-old quarry worker, after being exposed to fine quartz dust for 16 years in a German quarry, is on the waiting list for a lung transplant. The inhalation of the fine dust irreversibly damaged his lungs and facilitated the occurrence of fulminant mycobacterial and fungal infections, which have already led to a unilateral pneumonectomy and increasing respiratory failure. Despite regular monitoring by the occupational health and safety board, this dramatic development of silicosis could not be prevented.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141088313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Outpatient care in pulmonology - a scientific analysis and a position paper of the German Society of Respiratory Medicine (DGP)]. [肺科门诊护理--德国呼吸医学会(DGP)的科学分析和立场文件]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-05-01 Epub Date: 2024-03-20 DOI: 10.1055/a-2279-7787
Kaid Darwiche, Winfried Randerath, Ralf-Harto Hübner, Markus Rathmayer, Melanie Tiefgraber, Volkmar Borass, Anne Piening, Lars Hagmeyer, Juergen Hetzel, Ralf Eberhardt, Wolfgang Gesierich, Markus Unnewehr, Sebastian Boeing, Michael Wilke, Felix Herth, Torsten Bauer

Introduction:  The ambulantization of patient care that were previously provided as inpatient service is one of the goals of the current reform in the German healthcare system. In pulmonology, this particularly applies to endoscopic procedures. However, the real costs of endoscopic services, which form the basis for the calculation of a future so called hybrid DRG or in the AOP catalog, are unclear.

Methods:  After selection of use cases including endoscopic procedures which can be performed on an outpatient basis by a committee of experts the appropriate DRGs were identified from the § 21-KHEntgG data for 2022 published by the Institute for the Hospital Remuneration System (InEK). The costs were calculated from the respective InEK cost matrix added by the calculated material costs.

Results:  The use cases suitable for outpatient treatment were systematic endobronchial ultrasound (EBUS) with transbronchial needle aspiration (calculated costs € 2,175.60 without or € 3,315.60 including PET/CT), navigation-assisted bronchoscopy for peripheral lesions (depending on the methodology € 2,870.23 to €4,120.23) and diagnostic (flexible) bronchoscopy (€ 1,121.02).

Conclusion:  Outpatient treatment of endoscopic procedures that were previously performed inpatient is possible and necessary, and the costs calculated in this publication can form a reliable basis for appropriate reimbursement. Together with a structural quality that has been transformed to outpatient service and cross-sector cooperation, continued high-quality care for pneumological patients can be ensured.

简介德国医疗系统目前的改革目标之一,是将以前作为住院服务提供的病人护理工作救护车化。在肺科,这尤其适用于内窥镜手术。然而,作为未来所谓混合 DRG 或 AOP 目录计算基础的内窥镜服务的实际成本并不明确:方法:由专家委员会对包括可在门诊进行的内窥镜手术在内的使用病例进行筛选后,从医院薪酬系统研究所(InEK)公布的 2022 年§ 21-KHEntgG 数据中确定了相应的 DRGs。成本根据 InEK 的成本矩阵计算,并加上计算得出的材料成本:结果:适合门诊治疗的病例有系统支气管内超声(EBUS)和经支气管针吸术(不含 PET/CT 的计算费用为 2,175.60 欧元,含 PET/CT 的计算费用为 3,315.60 欧元)、针对周边病变的导航辅助支气管镜检查(视方法而定,为 2,870.23 欧元至 4,120.23 欧元)和诊断性(柔性)支气管镜检查(1,121.02 欧元):本出版物计算出的费用可作为适当报销的可靠依据。再加上已转变为门诊服务的结构质量和跨部门合作,可以确保为肺科病人提供持续的高质量医疗服务。
{"title":"[Outpatient care in pulmonology - a scientific analysis and a position paper of the German Society of Respiratory Medicine (DGP)].","authors":"Kaid Darwiche, Winfried Randerath, Ralf-Harto Hübner, Markus Rathmayer, Melanie Tiefgraber, Volkmar Borass, Anne Piening, Lars Hagmeyer, Juergen Hetzel, Ralf Eberhardt, Wolfgang Gesierich, Markus Unnewehr, Sebastian Boeing, Michael Wilke, Felix Herth, Torsten Bauer","doi":"10.1055/a-2279-7787","DOIUrl":"10.1055/a-2279-7787","url":null,"abstract":"<p><strong>Introduction: </strong> The ambulantization of patient care that were previously provided as inpatient service is one of the goals of the current reform in the German healthcare system. In pulmonology, this particularly applies to endoscopic procedures. However, the real costs of endoscopic services, which form the basis for the calculation of a future so called hybrid DRG or in the AOP catalog, are unclear.</p><p><strong>Methods: </strong> After selection of use cases including endoscopic procedures which can be performed on an outpatient basis by a committee of experts the appropriate DRGs were identified from the § 21-KHEntgG data for 2022 published by the Institute for the Hospital Remuneration System (InEK). The costs were calculated from the respective InEK cost matrix added by the calculated material costs.</p><p><strong>Results: </strong> The use cases suitable for outpatient treatment were systematic endobronchial ultrasound (EBUS) with transbronchial needle aspiration (calculated costs € 2,175.60 without or € 3,315.60 including PET/CT), navigation-assisted bronchoscopy for peripheral lesions (depending on the methodology € 2,870.23 to €4,120.23) and diagnostic (flexible) bronchoscopy (€ 1,121.02).</p><p><strong>Conclusion: </strong> Outpatient treatment of endoscopic procedures that were previously performed inpatient is possible and necessary, and the costs calculated in this publication can form a reliable basis for appropriate reimbursement. Together with a structural quality that has been transformed to outpatient service and cross-sector cooperation, continued high-quality care for pneumological patients can be ensured.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"302-319"},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights vom DGP-Kongress 2024 aus Sicht der YoungDGP. 从 YoungDGP 的角度看 2024 年 DGP 大会的亮点。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-05-01 Epub Date: 2024-05-17 DOI: 10.1055/a-2298-6312
Katharina Buschulte, Erik Büscher, Klaas Franzen, Armin Frille, Espen Groth, Julia Hoffmann, Andreas Knaack, Johannes Krönig, Christoph Lederer, Gabriela Leuschner, Eva Pappe, Nina Sicker, Finn Wilkens, Christoph Fisser
{"title":"Highlights vom DGP-Kongress 2024 aus Sicht der YoungDGP.","authors":"Katharina Buschulte, Erik Büscher, Klaas Franzen, Armin Frille, Espen Groth, Julia Hoffmann, Andreas Knaack, Johannes Krönig, Christoph Lederer, Gabriela Leuschner, Eva Pappe, Nina Sicker, Finn Wilkens, Christoph Fisser","doi":"10.1055/a-2298-6312","DOIUrl":"https://doi.org/10.1055/a-2298-6312","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"78 5","pages":"295-301"},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Medical societies in Germany call for a ban on flavors in e-cigarettes - A Position Paper of the German Respiratory Society (DGP) in cooperation with other professional associations and organizations]. [德国医学协会呼吁禁止在电子烟中使用香精--德国呼吸协会(DGP)与其他专业协会和组织合作撰写的立场文件]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-05-01 Epub Date: 2024-03-19 DOI: 10.1055/a-2282-9908
Alexander Rupp, Natascha Sommer, Stefan Andreas, Wulf Pankow, Reiner Hanewinkel, Harm Wienbergen, Anil Batra, Tilman Sauerbruch, Peter Kardos, Sabina Ulbricht, Folke Brinkmann, Robert Scheubel, Claus Vogelmeier, Wolfram Windisch

E-cigarettes are primarily used by teenagers and young adults. Flavors in e-cigarettes increase their attractiveness and encourage young people and adults to start using them. This exposes young people in particular to the risk of nicotine addiction and various toxic substances from the aerosol of e-cigarettes. There are indications that various flavors in e-cigarettes are harmful to health, although toxicological studies are still lacking for the majority of flavors. There is a need for independent scientific investigations in this area. The scientific societies involved are calling for a ban on flavors in e-cigarettes, a ban on disposable e-cigarettes, effective regulation of the sale of e-cigarettes and effective control and implementation of the provisions for the protection of minors.

电子烟的主要使用者是青少年和年轻人。电子烟中的香料增加了电子烟的吸引力,鼓励年轻人和成年人开始使用电子烟。这尤其使年轻人面临尼古丁上瘾的风险和电子烟气雾中的各种有毒物质。有迹象表明,电子烟中的各种口味对健康有害,尽管对大多数口味仍缺乏毒理学研究。有必要在这一领域开展独立的科学调查。相关科学协会呼吁禁止使用电子烟中的香精,禁止使用一次性电子烟,对电子烟的销售进行有效监管,并有效控制和执行保护未成年人的规定。
{"title":"[Medical societies in Germany call for a ban on flavors in e-cigarettes - A Position Paper of the German Respiratory Society (DGP) in cooperation with other professional associations and organizations].","authors":"Alexander Rupp, Natascha Sommer, Stefan Andreas, Wulf Pankow, Reiner Hanewinkel, Harm Wienbergen, Anil Batra, Tilman Sauerbruch, Peter Kardos, Sabina Ulbricht, Folke Brinkmann, Robert Scheubel, Claus Vogelmeier, Wolfram Windisch","doi":"10.1055/a-2282-9908","DOIUrl":"10.1055/a-2282-9908","url":null,"abstract":"<p><p>E-cigarettes are primarily used by teenagers and young adults. Flavors in e-cigarettes increase their attractiveness and encourage young people and adults to start using them. This exposes young people in particular to the risk of nicotine addiction and various toxic substances from the aerosol of e-cigarettes. There are indications that various flavors in e-cigarettes are harmful to health, although toxicological studies are still lacking for the majority of flavors. There is a need for independent scientific investigations in this area. The scientific societies involved are calling for a ban on flavors in e-cigarettes, a ban on disposable e-cigarettes, effective regulation of the sale of e-cigarettes and effective control and implementation of the provisions for the protection of minors.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"320-324"},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1